01
Aug

After a manufacturing issue scuttled their first attempt, Eli Lilly and Boehringer Ingelheim have won the FDA’s blessing to market their new diabetes drug, a late entrant into a crowded space.

…read more

Source: Lilly, Boehringer win FDA approval for once-rejected diabetes drug

    

0 No comments